Sökning: "Pharma"
Visar resultat 6 - 10 av 32 uppsatser innehållade ordet Pharma.
6. Exploration, Exploitation and Ambidexterity in the R&D of Pharmaceutical Companies
Magister-uppsats, Lunds universitet/Företagsekonomiska institutionenSammanfattning : Purpose: The purpose of this thesis is to find out what pharmaceutical companies are doing in exploitation and exploration to improve R&D productivity. This research will also investigate the implications of management and control theories in combining exploration and exploitation in the context of pharmaceutical R&D. LÄS MER
7. The impact on Key Performance Indicators after Merger & Acquisition
Magister-uppsats, Umeå universitet/FöretagsekonomiSammanfattning : Merger and Acquisition is an important activity for the companies involved in it. They are a method for the acquiring company to increase not only its market presence, but it also helps to increase share holders value and diversifies the product portfolio. LÄS MER
8. Antivaccinationsrörelsens avtryck i sociala medier
Kandidat-uppsats, Luleå tekniska universitet/Institutionen för ekonomi, teknik och samhälleSammanfattning : World health organization (WHO) har listat tio hot mot världshälsan varav två av dessa är pandemier och vaccinskepticism. Enligt forskare kommer pandemier drabba mänskligheten samtidigt som vaccinskepticismen ökar. LÄS MER
9. Information design for product visualisations : Developement of a information design for carton boxes
Uppsats för yrkesexamina på avancerad nivå, Luleå tekniska universitet/Institutionen för ekonomi, teknik, konst och samhälleSammanfattning : Eson Pac is a company that develops pharmaceutical packaging. One problem that thecompany currently has is that they do not have a basis for showing their products andthe information about them. This report presents the development of this to the company,through a degree project. LÄS MER
10. Licensing in Pharma - Value Creation and Appropriation
Magister-uppsats, Lunds universitet/Företagsekonomiska institutionenSammanfattning : We unify literature on licensing in the pharmaceutical industry and empirically verify pre-established and identify new determinants of value creation and appropriation based on a contemporary data set of licensing deals made between 2015 and 2020. We observe positive returns for licensor and licensee. LÄS MER